Microbiological profile and antimicrobial susceptibility in surgical site infections following hollow viscus injury

Journal of Gastrointestinal Surgery

Volumn 14, Issue 8, 2010, Pages 1304-1310

  Schnüriger, Beat ^a   Inaba, Kenji ^a   Eberle, Barbara M ^a   Wu, Tiffany ^a   Talving, Peep ^a   Bukur, Marko ^a   Belzberg, Howard ^a   Demetriades, Demetrios ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antimicrobial susceptibility; Hollow viscus injury; Microbiological profile; Surgical site infection; Trauma

Indexed keywords

ANTIINFECTIVE AGENT;

ABDOMINAL INJURY; ADULT; ARTICLE; BACTERIUM; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INJURY SCALE; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENETRATING TRAUMA; RETROSPECTIVE STUDY; SURGICAL INFECTION; ABDOMINAL INJURIES; BACTERIA; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROCEDURES; SURGICAL WOUND INFECTION; WOUNDS, PENETRATING;

ABDOMINAL INJURIES; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TRAUMA SEVERITY INDICES; WOUNDS, PENETRATING;

EID: 77954959512     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1231-x     Document Type: Article

References (47)

1. Morales CH, Villegas MI, Villavicencio R, Gonzalez G, Perez LF, Pena AM, Vanegas LE. Intra-abdominal infection in patients with abdominal trauma. Arch Surg 2004; 139: 1278-1285; discussion 1285.
2. Salim A, Teixeira PG, Inaba K, Brown C, Browder T, Demetriades D. Analysis of 178 penetrating stomach and small bowel injuries. World J Surg 2008; 32: 471-475.
3. Hofstetter SR, Pachter HL, Bailey AA, Coppa GF. A prospective comparison of two regimens of prophylactic antibiotics in abdominal trauma: cefoxitin versus triple drug. J Trauma 1984; 24: 307-310.
4. Delgado G, Jr., Barletta JF, Kanji S, Tyburski JG, Wilson RF, Devlin JW. Characteristics of prophylactic antibiotic strategies after penetrating abdominal trauma at a level I urban trauma center: a comparison with the East guidelines. J Trauma 2002; 53: 673-678.
5. O'Neill PA, Kirton OC, Dresner LS, Tortella B, Kestner MM. Analysis of 162 colon injuries in patients with penetrating abdominal trauma: concomitant stomach injury results in a higher rate of infection. J Trauma 2004; 56: 304-312; discussion 312-303.
6. Croce MA, Fabian TC, Stewart RM, Pritchard FE, Minard G, Kudsk KA. Correlation of abdominal trauma index and injury severity score with abdominal septic complications in penetrating and blunt trauma. J Trauma 1992; 32: 380-387; discussion 387-388.
7. Croce MA, Fabian TC, Patton JH, Jr., Lyden SP, Melton SM, Minard G, Kudsk KA, Pritchard FE. Impact of stomach and colon injuries on intra-abdominal abscess and the synergistic effect of hemorrhage and associated injury. J Trauma 1998; 45: 649-655.
8. Demetriades D, Lakhoo M, Pezikis A, Charalambides D, Pantanowitz D, Sofianos C. Short-course antibiotic prophylaxis in penetrating abdominal injuries: ceftriaxone versus cefoxitin. Injury 1991; 22: 20-24.
9. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF, Mills J. Risk of infection after penetrating abdominal trauma. N Engl J Med 1984; 311: 1065-1070.
10. Kirton OC, O'Neill PA, Kestner M, Tortella BJ. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. J Trauma 2000; 49: 822-832.
11. Schmidt-Matthiesen A, Roding H, Windolf J, Sommerfeldt D, Gutt C, Pannike A, Encke A. A prospective, randomised comparison of single- vs. multiple-dose antibiotic prophylaxis in penetrating trauma. Chemotherapy 1999; 45: 380-391.
12. Tyburski JG, Wilson RF, Warsow KM, McCreadie S. A trial of ciprofloxacin and metronidazole vs gentamicin and metronidazole for penetrating abdominal trauma. Arch Surg 1998; 133: 1289-1296.
13. Sims EH, Thadepalli H, Ganesan K, Mandal AK. How many antibiotics are necessary to treat abdominal trauma victims? Am Surg 1997; 63: 525-535.
14. Demetriades D. Antibiotic prophylaxis in penetrating abdominal injuries. S Afr J Surg 1989; Suppl: 5.
15. Fabian TC, Hoefling SJ, Strom PR, Stone HH. Use of antibiotic prophylaxis in penetrating abdominal trauma. Clin Ther 1982; 5 Suppl A: 38-47.
16. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23: 486-494.
17. Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Miscall BG, Fry DE. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214: 543-549.
18. Sturkenboom MC, Goettsch WG, Picelli G, in 't Veld B, Yin DD, de Jong RB, Go PM, Herings RM. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005; 60: 438-443.
19. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004; 23: 682-687.
20. Guembe M, Cercenado E, Alcala L, Marin M, Insa R, Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 2008; 21: 166-173.
21. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009; 63: 785-794.
22. Velmahos GC, Vassiliu P, Demetriades D, Chan LS, Murray J, Salim A, Sava J, Katkhouda N, Berne TV. Wound management after colon injury: open or closed? A prospective randomized trial. Am Surg 2002; 68: 795-801.
23. Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 1972; 13: 251-256.
24. Thadepalli H. Principles and practice of antibiotic therapy for post-traumatic abdominal injuries. Surg Gynecol Obstet 1979; 148: 937-951.
25. Durham RM, Olson S, Weigelt JA. Penetrating injuries to the stomach. Surg Gynecol Obstet 1991; 172: 298-302.
26. Thadepalli H, Lou MA, Bach VT, Matsui TK, Mandal AK. Microflora of the human small intestine. Am J Surg 1979; 138: 845-850.
27. Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 2005; 55: 965-973.
28. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006; 58: 205-210.
29. Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW. In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect (Larchmt) 2006; 7: 537-545.
30. Baquero F, Cercenado E, Cisterna R, de la Rosa M, Garcia-Rodriguez JA, Gobernado M, Perez JL, Manchado P, Martin R, Pascual A, Picazo J, Prats G, Rubio C, Snyder TA, Sanz-Rodriguez C. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. Rev Esp Quimioter 2006; 19: 51-59.
31. Ko WC, Hsueh PR. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. J Infect 2009; 59: 95-103.
32. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004; 24: 585-591.
33. Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002; 50: 569-576.
34. Eagye KJ, Kim A, Laohavaleeson S, Kuti JL, Nicolau DP. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt) 2009; 10: 323-331.
35. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003; 37: 997-1005.
36. Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, Vogel SB, Solomkin JS. Definition of the role of Enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 1995; 118: 716-721.
37. Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996; 131: 1193-1201.
38. Weigelt JA, Easley SM, Thal ER, Palmer LD, Newman VS. Abdominal surgical wound infection is lowered with improved perioperative Enterococcus and Bacteroides therapy. J Trauma 1993; 34: 579-584.
39. Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 2002; 89: 361-367.
40. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD. The microbiology of postoperative peritonitis. Clin Infect Dis 2001; 33: 1513-1519.
41. Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Malledant Y. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 2006; 12: 980-985.
42. Reik R, Tenover FC, Klein E, McDonald LC. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 2008; 62: 81-85.
43. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003; 36: 1433-1437.
44. Eliopoulos GM. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin Infect Dis 2003; 36: 473-481.
45. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710-721.
46. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42: 389-391.
47. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13: 1840-1846.